MPI Research is a world-leading provider of preclinical contract research services. Biopharmaceutical, medical device, animal health, agricultural, chemical and environmental Sponsors turn to us for fast, quality, reliable results in discovery, safety evaluation, bioanalytical and analytical testing services. Our experienced, highly skilled, and collaborative science team shares our Sponsors’ dedication to bringing safer and more effective products to humanity. Headquartered in Mattawan, Michigan, MPI Research is the world’s largest single-site preclinical contract research organization (CRO).
The breadth and depth of capabilities at MPI Research covers the spectrum of preclinical research, from discovery through regulatory filing
- Drug Safety/Preclinical Sciences
- Discovery Sciences
- Bioanalytical and Analytical Sciences
- Surgical Services and Medical Device Evaluation
Our scientists apply their vast experience and knowledge to design studies, provide customized services, and drive results that meet or exceed the needs of Sponsors. In fact, we measure our success by our Sponsors’ satisfaction.
The strengths of MPI Research range from expert pharmacokinetic and ADME studies to multi-species in vivo and surgical models; from extensive in vitro models and competencies to superior radiochemistry and molecular imaging capabilities; from a fully integrated platform of immunoassays, histology, pathology, immune-histochemistry, flow cytometry, telemetric readouts and behavioral assays to purpose-built, state-of-the-art laboratory facilities and equipment that place us on the cutting edge of our industry.
MPI Research approaches the life science enterprise as a partner with our Sponsors, understanding their needs, and sharing their commitment to delivering the most accurate, most reliable results quickly and cost-effectively.
MPI Research brings the latest technology and skills to preclinical research throughout the discovery and development process, starting at proof-of-concept testing all the way to regulatory submission (IND, NDA, PMA, EPA/OPPTS, 510K). We focus our proficiencies on the most challenging therapeutic needs of today, including, but not limited to:
- Metabolic diseases
- Cardiovascular diseases
- Infectious diseases
The commitment of MPI Research to detailed evaluation, expert interpretation, and fast turnaround assures Sponsors of the best data to drive decision-making, advance life science research, and benefit humankind. Learn more about how we go beyond expectations at www.mpiresearch.com.